Abnormalities, Multiple Clinical Trial
Official title:
Molecular Genetic Analysis of Fraser Syndrome and Fryns Syndrome
This study will examine blood or other tissue samples from patients with Fraser syndrome and
patients with Fryns syndrome to try to identify the gene responsible for these diseases.
Fraser syndrome is characterized by congenital abnormalities including cryptophthalmos (lack
of eyelid formation), syndactyly (webbed fingers or toes) and abnormal genitalia. Patients
may also have abnormalities of the nose, ears and larynx (voice box), cleft lip or palate,
and kidney agenesis. Fryns syndrome is characterized by hernia through the diaphragm, cloudy
cornea, coarse facial features, cleft lip or palate, abnormal fingers and toes, heart,
kidney and brain malformations and hydrocephalus (accumulation of fluid around the brain).
This protocol consists of laboratory study only; it does not involve patient care or patient
counseling.
Patients with Fraser syndrome or Fryns syndrome are eligible for this study. Parents and
healthy siblings of patients will also be included for genetic study, and parents of
children with undiagnosed multiple congenital anomalies syndromes will be included for
comparison study.
Participants will provide a blood sample (about 8 to 10 teaspoons from adults; 1 to 3
teaspoons from children) or sample of skin cells collected by swabbing the inner surface of
the cheek. Some patients may undergo a skin biopsy, in which a small skin sample (about
1/8-inch in diameter) is surgically removed. The tissue samples will be used to obtain DNA
(genetic material) for laboratory testing. A permanent cell line-a collection of cells grown
in the laboratory from the original tissue specimen-will also be established to enable
additional testing in the future.
We would like to determine the molecular genetic etiology of two rare human malformation
syndromes, Fraser syndrome (OMIM 219000) and Fryns syndrome (OMIM 229850). To date, we are
unaware of molecular genetic studies that have been performed in either syndrome.
We are planning to perform molecular genetic studies on DNA specimens from affected
individuals ascertained outside NIH by other clinicians and/or reported in the medical
literature. Should these studies prove fruitful, we would plan to expand this work to a
combined clinical and molecular study to fully delineate the phenotypes associated with
these disorders.
We plan to collect DNA specimens from affected patients and from unaffected siblings and
parents and to evaluate the specimens in the laboratory by linkage analysis, physical
mapping, candidate gene characterization and mutation screening. If the causative genes(s)
for either syndrome are identified, then mouse models of the diseases may be developed and
cell biologic studies of normal and mutant proteins may be undertaken.
The cloning of these genes would enable better characterization of human developmental
processes and improve patient counseling for individuals and families affected by these
diseases.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT00614367 -
Chromosomal Analysis of Single Cells in Human Embryos
|
N/A | |
| Completed |
NCT00795795 -
Preimplantation Genetic Screening in Women of Advanced Maternal Age
|
N/A |